Inventor · disambiguated record
Tindy Li
Also filed as: LI TINDY
5 granted patents·8 pending applications·30 citations·filing 2002–2021
76Inventor score
Files withGLAXOSMITHKLINE IP DEV LTD7BAYER PHARMACEUTICALS CORP4BAYER PHARMACEUTICLAS CORP1DIXON JULIE A1
Top patents by PatentIndex Score
13 records- 0185US6900205B21,8-Naphthyridine derivatives and their use to treat diabetes and related disordersBAYER PHARMACEUTICALS CORP·Filed 2002·Granted May 31, 2005·19 cites·36 claims
- 0277US10364256B2Biaryl pyrazoles as NRF2 regulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Jul 30, 2019·2 cites·15 claims
- 0376US7109196B21,8 Naphthyridine derivatives and their use to treat diabetes and related disordersBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Sep 19, 2006·7 cites·20 claims
- 0471US8829185B2Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisDIXON JULIE A·Filed 2012·Granted Sep 9, 2014·2 cites·5 claims
- 0569US2023047296A1Nrf2 REGULATORSGLAXOSMITHKLINE IP DEV LTD·Filed 2021·Application pending·0 cites
- 0659US2006189609A11, 8-Naphthyridine derivatives and their use to treat diabetes and related disordersBAYER PHARMACEUTICALS CORP·Filed 2006·Application pending·0 cites
- 0758US2020079759A1Nrf2 REGULATORSGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Application pending·0 cites
- 0850US2019002454A1NRF2 RegulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Application pending·0 cites
- 0946US2006063760A1Hydroxamic acids useful in the treatment of hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2004·Application pending·0 cites
- 1044US2009247590A1Indane amidesBAYER PHARMACEUTICLAS CORP·Filed 2005·Application pending·0 cites
- 1140US2022002272A1Bisaryl lactams as nrf2 activatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Application pending·0 cites
- 1237US10351530B2Arylcyclohexyl pyrazoles as NRF2 regulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Jul 16, 2019·0 cites·8 claims
- 1337US2018179167A1Nrf2 REGULATORSGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →